Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib—A cost-effectiveness analysis
出版年份 2018 全文链接
标题
Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib—A cost-effectiveness analysis
作者
关键词
Cost-effectiveness analysis, Hepatocellular carcinoma, Diarrhea, Hypertension, Cancer treatment, Monte Carlo method, Markov models, Palliative care
出版物
PLoS One
Volume 13, Issue 11, Pages e0207132
出版商
Public Library of Science (PLoS)
发表日期
2018-11-09
DOI
10.1371/journal.pone.0207132
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer
- (2018) Michal Sarfaty et al. EUROPEAN UROLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Me too-drugs with limited benefits — the tale of regorafenib for HCC
- (2017) Bishal Gyawali et al. Nature Reviews Clinical Oncology
- Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database
- (2016) Neehar D. Parikh et al. HEPATOLOGY
- Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
- (2016) H. K. Sanoff et al. ONCOLOGIST
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer
- (2015) Daniel A. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
- (2014) Amir Shlomai et al. SEMINARS IN CANCER BIOLOGY
- Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
- (2013) Calogero Cammà et al. HEPATOLOGY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Surveillance for hepatocellular carcinoma: in whom and how?
- (2010) Hashem B. El-Serag et al. Therapeutic Advances in Gastroenterology
- Commentary: Sorafenib Use in Patients with Advanced Hepatocellular Carcinoma and Underlying Child-Pugh B Cirrhosis--Evidence and Controversy
- (2009) A. X. Zhu et al. ONCOLOGIST
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- The global impact of vaccination against hepatitis B: A historical overview
- (2008) Alessandro R. Zanetti et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started